Position in GANX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$436,473
+$8,726 QoQ
Shares Held
215,012
-2.5% QoQ
Ownership
0.493%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 49 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in GANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. GANX ranks #305 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in GANX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $436,473 | 215,012 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $427,747 | 220,489 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $261,208 | 81,121 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $248,997 | 140,677 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $58,742 | 32,635 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,817 | 43,360 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $76,089 | 35,227 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $15,049 | 8,455 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,619 | 11,422 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,696 | 8,673 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $45,784 | 14,023 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $27,236 | 8,304 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $42,322 | 9,447 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,750 | 4,305 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $22,814 | 7,289 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $13,437 | 4,122 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $23,079 | 6,411 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $16,769 | 4,100 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $56,998 | 10,497 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $50,178 | 6,740 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $41,000 | 4,100 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $91,086 | 6,105 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||